Navigation Links
EYESI Ophthalmosurgical Simulator

ProductsEYESI Ophthalmosurgical Simulator
Company VRmagic GmbH
Item EYESI Ophthalmosurgical Simulator
Features Basic Training Module 1

Navigation (needle*): Training of precise navigation with surgical instruments viewed under the stereo microscope.

Object manipulation (tweezers*): Using tweezers to manipulate solid objects in the vitreous body and to remove objects from the vitreous body.

Vitrectomy (vitrectomy unit*): Learning how to use the vitrectomy unit correctly and how to regulate the cutting speed and flow or suction. * Every chapter also includes simulation of the surgery lamp.

Membrane Simulation Module
Simulation equipment included in the module:

  • Various intraocular membranes need to be removed.
  • The vitrectomy unit and a variety of light sources, tweezers, hooks and scissors are available.
  • Vitrectomy unit, configurable for flow or vacuum control
  • Monitoring and display of retina and lens injuries
  • Microscope control by pedal, configurable pedal for control of equipment and instruments
Description EYESI is a simulator for intraocular surgery. The use of advanced computer technology gives the surgeon the feeling that he is experiencing real intraocular surgery. During simulated surgery the surgeon uses instruments that feel and function just like the real ones. The view through the EYESI microscope is similar to the familiar stereo vision through the surgical microscope. The course of surgery is not predefined but is dependent on the way the surgeon works. Tissue reaction is individually computed in each training session. The system is intuitively controlled through a touch display. EYESI allows you to experience intraocular surgery realistically outside the operating room.

Ophthalmosurgical training It takes a long time to gain broad experience. The learning process, in particular the handling of complications, is limited by the number of cases in hospitals. Wetlab training is only realistic to a certain extent. Beginners can only gain surgical experience on patients, thus increasing the risk of complications. The lack of routine in treating rare cases can make it necessary to refer patients to specialized hospitals. It is difficult to produce objective documentation of training successes and surgical ability.

Optimization potential An ideal training system generates realistic surgery situations and enables trainee surgeons to get familiar with standard surgery procedures as well as the treatment of rare cases and complications. The handling of new surgical instruments and the use of new surgical procedures can be practiced without any risk for the patient. The surgical ability of trainee doctors can be tested and assessed objectively. The training method is available at any time and without any effort.

The next step in training, teaching and instruction
Training with EYESI is realistic and is not on patients. The risk of complications inherent in conventional practical training is reduced to a minimum. With its autodidactic training methods and easy accessibility EYESI offers significantly better efficiency in training and further training. Reproducibility and documentation options ensure that surgical abilities are assessed objectively. EYESI enables optimum preparation in the use of new instruments, equipment and surgical techniques. Surgery with EYESI is fun.

Info VRmagic GmbH
Customer Service: +49 (0) 621 / 400 416 - 0
Web site: http://www.vrmagic.com/index_e.html

Related medicine products :

1. Clearview H. pylori II
2. Clearview Chlamydia
3. Clearview Mono-plus II
4. Clearview hCG Combo
5. Clearview hCG Urine II -- Dipstick
6. Clearview hCG Combo w/ Reference Line
7. Clearview hCG Urine II -- Cassette
8. Clearview C DIFF A
9. Clearview Troponin I
10. Clearview Exact Influenza A & B
11. Clearview hCG II - Urine Cassette
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
For the quantitative in vitro determination of Alanine Aminotransferase (ALT) in serum and plasma....
... introduces the Tag-It™ Cystic Fibrosis Kit, the ... genotyping. With validated performance criteria, this highly ... superior mutation coverage for carrier screening in ... in newborns. ,The Tag-It™ Cystic Fibrosis ...
Medicine Products:
(Date:9/30/2014)... New York, NY (PRWEB) September 30, 2014 ... and falling demand have hampered growth in the ... Popular diets have caused consumers to moderate their ... growing consumer preferences for premium varieties shrunk the ... bread products. Successful operators proactively responded by introducing ...
(Date:9/30/2014)... been awarded a three-year $1.7 million grant from ... new imaging technologies and data analysis techniques that ... of neurons in the brain interact to process ... the precise interactions between millions of nerve cells ... alterations in these interactions that may be responsible ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
(Date:9/30/2014)... 2014 Regenerative Medicine Solutions (RMS) is ... in Nashville, Tennessee. RMS welcomes the launch of an ... expansion of a new treatment center for the Lung ... Apnea Institute to Nashville, the hope is to bring ... both diagnosed and undiagnosed. With Nashville being a hub ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- Medicare should cover low-dose ... risk for the disease, a coalition of more than ... which includes the Lung Cancer Alliance, the Society of ... Cancer Society and the American Society of Clinical Oncology, ... the U.S. Centers for Medicare & Medicaid Services (CMS). ...
Breaking Medicine News(10 mins):Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Regenerative Medicine Solutions Expanding 2Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2
... Small Business Committee Leaders to Press for Affordable ... 24 In advance of tomorrow,s,Finance Committee hearing ... Kerry (D-Mass.) and Olympia J. Snowe (R-Maine), Chairman ... and Entrepreneurship,sent a letter to the leaders of ...
... from a Phase I/II clinical trial of a novel ... In 26 patients with advanced solid tumors, treatment with ... yielding plasma concentrations above the expected therapeutic threshold, says ... in Montreal, Canada. Thallion has produced and tested ...
... seven exceptionally talented and creative investigators in the early ... Health Science (NIEHS), part of the National Institutes of ... made under NIEHSs Outstanding New Environmental Sciences (ONES) program. ... of our efforts to help establish the careers of ...
... supports vitamins for respiratory health , , WEDNESDAY, Oct. 24 (HealthDay ... of drinks a day may help keep the doctor away, ... daily dose of alcohol helps the heart, this study suggests ... for smokers. , "This is the biggest study that,s ever ...
... Oct. 24 Thelen Reid Brown Raysman &,Steiner ... group has,successfully assisted long-time client The Doctors Company ... major provider of healthcare liability,insurance, for an aggregate ... share in cash. (Logo: http://www.newscom.com/cgi-bin/prnh/20071016/AQTU238LOGO ) ...
... trend, PHILADELPHIA, Oct. 24 Governor Edward ... Reduction of Error,Fund (Mcare) claims have dropped by ... result of reforms, more insurers are writing malpractice ... when it comes to medical malpractice,",Governor Rendell said ...
Cached Medicine News:Health News:Kerry, Snowe Push Finance Committee on Small Business Health Care 2Health News:Kerry, Snowe Push Finance Committee on Small Business Health Care 3Health News:Phase I pharmacokinetic study of ECO-4601, a novel bifunctional targeting agent 2Health News:NIEHS awards outstanding new environmental scientists 2Health News:Drink or Two a Day May Help Lungs 2Health News:Drink or Two a Day May Help Lungs 3Health News:Drink or Two a Day May Help Lungs 4Health News:Thelen Assists The Doctors Company in Acquisition of SCPIE Holdings Inc. 2Health News:Governor Rendell Says Mcare Claims and Costs Are 50 Percent Lower Than in 2003 2
(Date:9/30/2014)... 30, 2014   Easy Breathe , the fastest ... announced that it now offers the revolutionary AirSense ... the first sleep apnea therapy devices with internal cellular ... to track and share real-time data on each user,s ... CPAP therapy.  In addition, the internal modem allows the ...
(Date:9/30/2014)... ORANGE , N.J. and NEW BRUNSWICK, N.J., Sept. 30, ... affiliation agreement that allows Kessler Foundation and New ... advance biomedical research, education and patient care programs ... president and chief executive officer of Kessler Foundation ... New Jersey Health Foundation. "The experience ...
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern European ... established medical-device providers as well as new medical-device manufacturers ... while simultaneously looking at ways to reduce the cost ... distributors is one of the effective means to achieve ... distribution market in Eastern European and provides profiles of ...
Breaking Medicine Technology:Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3